Get the Stockscreener App
609.82
1.10%
6.64
After Hours:
608.00
-1.82
-0.30%
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $609.82, with a volume of 1.78M.
It is up +1.10% in the last 24 hours and up +0.80% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$603.18
Open:
$609.96
24h Volume:
1.78M
Relative Volume:
0.90
Market Cap:
$225.48B
Revenue:
$45.20B
Net Income/Loss:
$6.87B
P/E Ratio:
33.53
EPS:
18.1888
Net Cash Flow:
$6.75B
1W Performance:
-0.65%
1M Performance:
+0.80%
6M Performance:
+23.02%
1Y Performance:
+24.10%
1-Day Range:
$606.15
$615.24
1-Week Range:
$594.82
$615.24
52-Week Range:
$435.27
$647.00
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, NTRA, IQV, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
609.82 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
200.14 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
328.93 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
261.77 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
146.93 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Initiated | DZ Bank | Buy |
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Dec-01-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MarketWatch
Thermo Fisher stock gains on UBS upgrade and solid Q2 growth - ad-hoc-news.de
Thermo Fisher Scientific Share Price Today (TMO) | Live Chart, News & Stock Market - TechGraph
Thermo Fisher Drew Two Upgrades Near Its Highs. Here’s Where the Stock Could Go - TIKR.com
Thermo Fisher stock gains analyst support as UBS lifts target to 730 dollars - ad-hoc-news.de
Thermo Fisher, Wells Fargo, Nutrien And More On CNBC’s ‘Final Trades’ - Benzinga
Thermo Fisher stock heads into the open after a 0.4% loss - ad-hoc-news.de
UBS Upgrades Thermo Fisher Scientific to Buy From Neutral, Adjusts Price Target to $730 From $540 - Moomoo
Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says - Yahoo Finance
UBS upgrades Thermo Fisher Scientific stock rating on growth outlook By Investing.com - Investing.com Canada
Thermo Fisher stock slips as dividend date nears - ad-hoc-news.de
Thermo Fisher stock heads into the open after a 1.75 percent drop - AD HOC NEWS
Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market - MarketWatch
If You Invested $1000 In Thermo Fisher Scientific Stock 15 Years Ago, You Would Have This Much Today - Benzinga
Thermo Fisher (NYSE:TMO): Can New Products Justify Its Valuation? - Kalkine Media
Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others - Yahoo Finance UK
Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus - Zacks Investment Research
IVD Raw Material Market Report Now Available — Forecasts Market Growth from $21.5B (2026) to $31.1B by 2031, Profiling Merck KGaA, Thermo Fisher, Bio-Techne, Fapon Biotech, and 21 Other Key Players - uk.finance.yahoo.com
Thermo Fisher stock heads into the open after a modest recent gain - ad-hoc-news.de
Thermo Fisher stock holds steady after solid mid-year results - AD HOC NEWS
Thermo Fisher Scientific (NYSE:TMO): Can Demand Outweigh Macro Risks? - Kalkine Media
Is Thermo Fisher Scientific (NYSE:TMO) Ready for Another Breakout? - Kalkine Media
Thermo Fisher Scientific Inc. (TMO) Stock Analysis: A Leading Healthcare Giant with Strong Revenue Growth Prospects - DirectorsTalk Interviews
Thermo Fisher Scientific (NYSE:TMO) Shows Strong Technical Breakout Setup - ChartMill
Thermo Fisher CEO: ‘Society broadly embraces the breakthroughs’ - ft.com
Thermo Fisher stock trades near consensus target as guidance supports outlook - AD HOC NEWS
How Thermo Fisher’s New Workflow-Focused Lab Instruments At Thermo Fisher Scientific (TMO) Has Changed Its Investment Story - webull.com
Should You Continue to Hold TMO Stock in Your Portfolio? - TradingView
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Baird Adjusts Price Target on Thermo Fisher Scientific to $686 From $652, Keeps Outperform Rating - marketscreener.com
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader to Help Simplify Protein, Cell and Microbial Analysis - Business Wire
Thermo Fisher (NYSE: TMO) insider uses stock to cover taxes instead of selling on market - Stock Titan
Thermo Fisher (NYSE: TMO) CAO has 49.899 shares withheld to cover tax or exercise costs - Stock Titan
Thermo Fisher Scientific (NYSE: TMO) CEO uses shares to cover taxes and discloses trust holdings - stocktitan.net
Thermo Fisher (NYSE: TMO) HR chief uses 394 shares to cover exercise price or tax liability - Stock Titan
Equity award costs paid in stock at Thermo Fisher (TMO) - Stock Titan
Thermo Fisher Scientific to Present at the Morgan Stanley 24 - Business Wire
Thermo Fisher Scientific (TMO) Unveils New Tools For Electron Microscopy And Isotope Analysis - Yahoo Finance
Thermo Fisher (NYSE: TMO) executive to sell 4,133 shares - stocktitan.net
Is Thermo Fisher Scientific Stock Outperforming the Nasdaq? - Barchart.com
Thermo Fisher Scientific Inc. (TMO): Investor Outlook with a 1.49% Potential Upside and Strong Buy Ratings - DirectorsTalk Interviews
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Thermo Fisher Scientific Introduces the Thermo Scientific™ EMPAD™ G2 Electron Detector to Advance Materials Research - BioSpace
Thermo Fisher (NYSE: TMO) CEO exercises options, sells 275 shares - Stock Titan
Thermo Fisher Scientific Launches First Orbitrap Mass Spectrometers for Isotope Ratio Analysis, Enabling More Labs to Decode the Story Behind a Sample - finance.yahoo.com
Thermo Fisher (NYSE: TMO) CEO exercises options, sells 20K shares - stocktitan.net
Thermo Fisher Scientific (TMO) Stock Fair Value Rises After Q2 Strength And Analyst Revisions - finance.yahoo.com
Thermo Fisher (NYSE: TMO) holder Marc Casper plans another stock sale - Stock Titan
Portfolio Design Labs LLC Takes $1.53 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):